NXPL · NextPlat Corp

NextPlat Corp's preliminary Q1 2026 results highlight a successful turnaround, with consolidated gross margins expected to jump above 34% from 20% in full-year 2025, driven by a strategic shift to higher-margin contracted healthcare services including 340B and medication fulfillment contracts. Despite a sequential decline in Healthcare Operations revenue to $6.7 million from $9.6 million in Q4 2025, the segment's gross margin is set to reach nearly 39%, reflecting a 115% sequential improvement and 99% year-over-year gain. This margin expansion stems from direct engagement with 340B customers and a record five new contracts signed late last year, with onboarding commencing in July 2026 to fuel further revenue growth. Operational efficiency gains are evident in the anticipated 9% or over $0.4 million reduction in operating expenses versus Q4 2025, supporting the company's goal of positive operating income in Q3 2026. A solid balance sheet underpins these efforts, featuring $11 million in cash, $14.3 million in working capital, and zero unsecured debt as of March 31, 2026, with Q2 cash expected to rise due to payment timing. CEO David Phipps emphasized broad-based improvements across healthcare operations and e-commerce, positioning NextPlat for top- and bottom-line growth throughout 2026 amid nationwide expansion and a growing pipeline with government and military customers.